Italy, Switzerland and Austria have banned the sale of anti-flu vaccines by Swiss drug-maker Novartis.
The move follows a report by Novartis of small particles in the vaccine. The pharmaceutical giant has said it is confident its flu vaccines are safe.
Anne-Claire Siegrist, President of the Swiss Vaccination Commission, said the jabs are not dangerous:
“The only potential risk, as we’ve seen in past years with the flu vaccine, is that particles can cause a slightly worse inflammation in the hours following the vaccination.”
When asked what she advises patients who have already had the vaccine, the president of the Swiss Vaccination Commission said:
“Those who’ve already been vaccinated have nothing to worry about, there is nothing to date that gives us any reason to think there is a problem. But just to be sure, we are asking doctors to wait a day or two or three until we can say, for sure, that there is nothing to worry about.”
The move comes as drug-makers are struggling to meet demand in Switzerland, where it is estimated only 1 million of 1.3 million doses ordered will be delivered.
The vaccines concerned are Agrippal, Fluad and Influpozzi.
Latest world news
Evacuations increase as wildfire spreads in Alberta, Canada
Six days on, survivors are found in collapsed Kenya building
‘We need everything’, Ecuador quake survivor tells euronews
Air strike kills dozens in Syrian refugee camp
Playing for Palmyra – Russia holds a concert in the ruins
Wires > News
- 05:10 CET Exclusive – Top reason Americans will vote for Trump: ‘To stop…
- 04:06 CET Singapore, Australia to jointly develop military training areas
- 03:57 CET Air strikes hit camp in Syria, U.S. condemns Assad statement
- 02:13 CET Obama, Mexican president discuss immigration, anti-drugs fight -…
- 01:59 CET Philippine fishermen favour strong president to end China’s…
- 00:31 CET Trump says Britain would be better off without EU – Fox News
- 21:30 CET Depression reigns as EU presidents debate future of Europe
- 20:39 CET Ex-Venezuela parliament head sues News Corp over drug article